benzonitrile has been researched along with Parkinson Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, Z; Chen, Y; Coffman, KJ; Galatsis, P; Hayward, MM; Henderson, JL; Hirst, WD; Houle, C; Jasti, J; Kormos, BL; Kurumbail, RG; Needle, E; Noell, GS; Steyn, SJ; Verhoest, PR; Wager, TT | 1 |
1 other study(ies) available for benzonitrile and Parkinson Disease
Article | Year |
---|---|
Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor.
Topics: Amino Acid Sequence; Animals; Area Under Curve; Brain; Crystallography, X-Ray; Drug Discovery; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mice, Inbred C57BL; Mice, Transgenic; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutation, Missense; Nitriles; Parkinson Disease; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proteome; Pyrimidines; Pyrroles; Rats | 2015 |